Methodological Concerns Regarding: "Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?"

OriginalsprogEngelsk
TidsskriftAnnals of Surgical Oncology
Vol/bind32
Udgave nummer1
Sider (fra-til)503-504
Antal sider2
ISSN1068-9265
DOI
StatusUdgivet - jan. 2025

Citationsformater